MSD obtains Singapore HSA interim authorisation for Covid-19 antiviral
Lagevrio is indicated for Covid-19 patients who are at risk of disease progression to severe Covid-19 and/or hospital admission.
Singapore
Latest in
Singapore
Partner content
How Singapore is positioning itself at the forefront of aquaculture innovation
As investment in agri-food tech hits record-breaking levels, Singapore is helping entrepreneurs, industry, academia and the investment community to come…
Novavax receives interim authorisation in Singapore for Covid-19 vaccine
The initial doses of the Nuvaxovid vaccine are anticipated to reach Singapore by the end of next month.
Singapore HSA approves Pfizer-BioNTech’s shot for children
The expert committee also recommended the usage of booster shot to inoculate adults aged 18 to 29 years.
Novavax seeks interim authorisation for Covid-19 vaccine in Singapore
The company’s filing includes positive clinical data from two Phase III trials.
Sen-Jam and Duke-NUS to initiate Phase II Covid-19 therapy trial in Nepal
A combination of a non-steroidal anti-inflammatory drug and antihistamine, SJP-002C can potentially prevent SARS inflammation.
Seagen and RemeGen enter up to $2.6bn deal for cancer drug
Disitamab vedotin uses a combination of Seagen’s drug-linker technology with a new HER2 antibody of RemeGen.
Singapore’s GIC to invest $1bn in Grifols subsidiary Biomat
The proceeds from the GIC investment will be used to pay off the debt and grow Grifols’s US plasma centre…